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INTRODUCTION
Considerable work is currently ongoing to investigate the
molecular mechanisms that regulate new blood vessel
formation (i.e. angiogenesis) and the separate process of blood
vessel regression (Hanahan and Folkman, 1996; Hanahan,
1997; Folkman, 1997). Both in vitro and in vivo studies have
identified many classes of molecules that are relevant to these
events such as angiogenic cytokines, integrins, extracellular
matrix, proteinases and proteinase inhibitors (Vernon and Sage,
1995; Senger, 1996; Pepper et al., 1996; Werb et al., 1999;
Haas and Madri, 1999). Recent work has identified several
molecules that can induce regression of angiogenic vessels
within tumors such as fragments of plasminogen (Plg) (i.e.
angiostatin) and collagen type XVIII (i.e. endostatin) (O’Reilly
et al., 1994; O’Reilly et al., 1997; Sage, 1997) or antagonists
of integrin function such as cyclic RGD peptides and anti-
integrin monoclonal antibodies (Brooks et al., 1994). In
addition, withdrawal of vascular endothelial growth factor
from tumor angiogenic vessels induces vessel and tumor
regression (Benjamin and Keshet, 1997; Benjamin et al.,
1999). Angiopoietins, by controlling endothelial cell (EC)-
vascular smooth muscle cell interactions, also appear to
regulate a balance between vessel growth and regression
(Hanahan, 1997; Holash et al., 1999). Angiopoietin-1 knockout
mice have revealed abnormal vascular structures that may be
causally related to altered EC-extracellular matrix (ECM)
interactions, although no definite mechanism for these findings
has yet been reported (Suri et al., 1996).
Many studies have shown that ECs induce the expression of
various proteolytic enzymes during angiogenic events (Herron
et al., 1986; Mignatti et al., 1989; Fisher et al., 1994; Iruela-
Arispe et al., 1995; Mignatti and Rifkin, 1996; Moses et al.,
1996; Pepper et al., 1996; Haas et al., 1998; Hiraoka et al.,
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Here, we describe a new function for plasmin and matrix
metalloproteinases (MMPs), which is to regulate the
regression of capillary tubes in three-dimensional
extracellular matrix environments. Using a well-described
capillary morphogenesis system in three-dimensional
collagen matrices, a new model of capillary regression has
been established by adding plasminogen to the culture
medium. Plasminogen is converted to plasmin by
endothelial cell plasminogen activators which then
induces matrix metalloproteinase-dependent collagen gel
contraction and capillary regression. Plasminogen addition
results in activation of MMP-1 and MMP-9, which then
results in collagen proteolysis followed by capillary
regression. The endothelial cells undergo apoptosis
following gel contraction as detected by flow cytometric
analysis as well as by detectable caspase-3 cleavage and
caspase-dependent cleavage of the actin cytoskeletal
regulatory protein, gelsolin. In addition, directly
correlating with the contraction response, tyrosine
phosphorylation of p130cas, an adapter protein in the focal
adhesion complex, is observed followed by disappearance
of the protein. Proteinase inhibitors that block MMPs
(TIMP-1 or TIMP-2), plasminogen activators (PAI-1) or
plasmin (aprotinin) completely block the gel contraction
and regression process. In addition, chemical inhibitors of
MMPs that block capillary regression also block MMP-1
and MMP-9 activation suggesting that a key element in this
regression response is the molecular control of MMP
activation by endothelial cells. Blocking antibodies directed
to MMP-1 or MMP-9 interfere with capillary regression
while blocking antibodies directed to PAI-1 accelerate
capillary regression suggesting that endogenous synthesis
of PAI-1 negatively regulates this process. These data
present a novel system to study a new mechanism that may
regulate regression of capillary tubes, namely, plasmin and
MMP-mediated degradation of extracellular matrix. 
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1998). Relevant proteinases in these events include Plg
activators (PAs), and matrix metalloproteinases (MMPs)
(Pepper et al., 1996; Carmeliet and Collen, 1998; Nagase and
Woessner, 1999; Werb et al., 1999). Their role in this process
has been thought to be related to ECM breakdown, a step
apparently required for EC morphogenesis (Mignatti et al.,
1989; Fisher et al., 1994; Hiraoka et al., 1998). In support of
their role in EC morphogenesis is that proteinase inhibitors,
such as TIMPs, have been shown to inhibit angiogenesis
(Moses et al., 1990; Moses, 1997). Recent data strongly
implicates the role of membrane type MMPs (MT-MMPs) in
EC and other cellular invasive and morphogenic behaviors in
three-dimensional extracellular matrices (Hiraoka et al., 1998;
Hotary et al., 2000). In contrast, secreted MMPs, such as
MMP-1, MMP-2 and MMP-9, were not shown to play a role
in collagen gel invasion and morphogenesis of MDCK cells
in this latter study (Hotary et al., 2000). Thus, despite the
induction of secreted MMPs during many types of cellular
morphogenesis, their role in these events is unclear. 
A very interesting question, and one that has been only
minimally investigated, is whether or not some EC-derived
proteinases may be induced during angiogenesis to regulate
the process of vascular regression rather than morphogenesis.
During angiogenesis, the final pattern of blood vessel
formation is governed by the concurrent and dual regulation of
EC morphogenesis and regression (Ausprunk et al., 1978;
Clark, 1996; Folkman, 1997). This formation and regression of
blood vessels is characteristically observed within granulation
tissue during wound healing responses or during the female
reproductive cycle (Moses et al., 1996; Clark, 1996; Madri et
al., 1996). The mechanisms regulating vascular regression
during these events are unknown, however, past and recent
literature has shown that other tissue regression phenomena,
such as mammary gland involution following the cessation
of lactation, involves ECM proteolysis (Talhouk et al., 1992;
Sympson et al., 1994; Werb et al., 1996). These proteolytic
events lead to mammary epithelial cell apoptosis and
regression of mammary epithelial ducts (Boudreau et al., 1996)
secondary to an imbalance of proteinase activity relative to
proteinase inhibitor activity (Werb et al., 1996). Since the ECM
comprises the scaffold on which tissues assemble, differentiate
and survive, disruption of this scaffold can result in tissue
regression through mechanisms such as apoptosis (Meredith et
al., 1993; Boudreau et al., 1996). These concepts, generated
from studies of mammary gland involution, are likely to be
of general importance to other types of cellular regression
responses including those involving the vasculature.
Here, we present an in vitro model of capillary tube
regression that is directly related to these latter concepts and
that involves ECM proteolysis. We report on a novel function
for plasmin and matrix metalloproteinases in the context of EC
function, which is to regulate vascular regression in three-
dimensional extracellular matrix environments. The addition of
plasminogen (Plg) to a model of capillary morphogenesis in
three-dimensional collagen matrices results in marked EC-
mediated collagen gel contraction and regression of capillary
tube networks. This occurred through the conversion of Plg
to plasmin through EC plasminogen activators (PAs), which
then activated matrix metalloproteinases (MMPs). Proteinase
inhibitors or blocking antibodies directed to MMPs interfered
with this contraction/regression event. Evidence for EC
apoptosis was observed during these events by caspase-
dependent cleavage of the actin regulatory protein, gelsolin.
Blocking antibodies to PAI-1 markedly accelerated the MMP-
dependent regression response. These data support the concept
that plasmin and MMPs, such as MMP-1 and MMP-9,
can participate in endothelial cell-mediated collagen gel
contraction and regression of capillary tubes. 
MATERIALS AND METHODS
Human umbilical vein endothelial cells were obtained from Clonetics
Corp. (San Diego, CA), and were grown according to the supplier or
as described (Maciag et al., 1979). ECs were used in our experiments
from passages 2-6. The EC morphogenesis assay in three-dimensional
collagen gels was performed as described using either gels at 3.75 or
5 mg/ml of collagen type I (Davis and Camarillo, 1996; Salazar et al.,
1999). Glu-Plg (American Diagnostica, Greenwich, CT) was added at
various concentrations to the serum-free culture medium which
contained Medium 199, a 1:200 dilution of the Reduced Serum
supplement II, 50 m g/ml of ascorbic acid, 50 ng/ml of phorbol ester,
and 40 ng/ml of recombinant VEGF-165 and 40 ng/ml of FGF-2.
Recombinant TIMP-1 and TIMP-2 as well as monoclonal antibodies
directed to MMP-1 (Blocking-COMY 4A2) (Non-blocking-III7)
(Birkedal-Hansen et al., 1998), MMP-2 (CA-4001) (Margulies et al.,
1992), MMP-9 (GE-213) (Soini et al., 1994) were from Chemicon
Corp (Temecula, CA). Recombinant PAI-1, the MMP inhibitor
GM6001, and carboxypeptidase B were from Calbiochem (La Jolla,
CA) and aprotinin was from American Diagnostica. Another
monoclonal antibody directed to MMP-1 (41-1E5) was obtained from
Oncogene Research Products (Cambridge, MA) while an anti-MMP-
3 (4B7.3), and anti-gelsolin monoclonal antibodies were obtained
from Sigma Corp. (St Louis, MO). Monoclonal antibodies to caspase-
3, p130cas and phosphotyrosine (PY20) were obtained from
Transduction Laboratories (Lexington, KY). A rabbit polyclonal
antiserum directed to the MMP-9/TIMP-1 complex purified from HL-
60 cell promyelocytic leukemia cells was utilized as previously
described (Davis and Martin, 1990). Sheep polyclonal antibodies
directed to PAI-1 and PAI-2, which block function, were purified
using protein G-sepharose and were obtained from Chemicon Corp.
Rat tail collagen type I was prepared as described (Bornstein, 1958).
Fluorescein isothiocyanate, phorbol ester, Protein G-Sepharose and
a 2 macroglobulin were obtained from Sigma Corp.
Plasminogen-induced endothelial cell contraction of
collagen gels
EC cultures were prepared as described above and as previously
described (Davis and Camarillo, 1996) with or without the addition
of Plg. In most cases, Plg was added at 2 m g/ml at the initiation of
culture. Cultures were fixed at 48 hours with 3% glutaraldehyde in
PBS, pH 7.5, for at least 30 minutes prior to additional manipulation.
In some cases, cultures were stained with 0.1% toluidine blue in borax
and then destained prior to visualization and photography. Contracted
gels were measured by determining the diameter of the gel in two
representative perpendicular axes. The average diameter was then
used to calculate the area of the gel which used a formula to calculate
the area of an ellipse. In some experiments, protease inhibitors, or
anti-MMP antibodies were added at the indicated concentrations in
the figure legends. In some experiments, contracted or non-contracted
gels were digested with bacterial collagenase and the resulting cell
pellet was fixed with 70% ethanol. The cells were then further
processed for flow cytometric apoptosis analysis by staining with
propidium iodide as described (Maxwell and Davis, 2000a; Maxwell
and Davis, 2000b). In other experiments, conditioned medium was
collected to examine differential proteinase expression over a 72 hour
period of culture. Conditioned medium samples were run on 8.5%
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SDS-PAGE gels, and after protein transfer to PVDF membranes,
western blots were performed as described (Salazar et al., 1999) using
chemiluminescence to examine protein expression patterns. In
addition, gelatin zymograms were performed in the presence or
absence of Plg added in the SDS-PAGE gel as described (Heussen and
Dowdle, 1980; Davis and Martin, 1990). To visualize proteinase
bands, 10 mM Tris-HCl, pH 7.5, with 5 mM CaCl2 was used for
zymograms without added Plg while gels containing Plg used 10 mM
Tris-HCl, pH 7.5, with 5 mM EDTA to inhibit MMPs but allow the
visualization of Plg activators. EC/collagen gels were also extracted
in some cases to examine gelsolin expression as described (Salazar et
al., 1999).
Reverse-transcriptase PCR (RT-PCR) analysis of
differential gene expression
Cultures were established, total RNA was obtained and cDNA was
synthesized as previously described (Salazar et al., 1999). A G3PDH
primer set was utilized to show that equivalent amounts of cDNA were
present in each sample (0, 8, 24, 48 hours) to standardize a stable
expression pattern over the time course. The RT-PCR primer sets with
their 5¢ -3¢ sequences used for this study are listed below. For each
gene pair, the first primer was the upstream primer while the second
primer was the downstream primer. 
MMP-1-ATTGGAGCAGCAAGAGGC; GTCCACATCTGCTCTT-
GGC
MMP-2-TGGCAGTGCAATACCTGAAC; CAAGGTCCATAGCT-
CATCGTC
MMP-3-CCTACTGTTGCTGTGCGTG; CAGCCTCTCCTTCATA-
CAGC
MMP-9-GAGGAATACCTGTACCGCTATG; CAAACCGAGTT-
GGAACCAC
MT1-MMP-AAAGCAGCAGCTTCAGCC; CTCGGCAAAGAA-
GATCATG
TIMP-1-CACCAGAGAACCCACCATG; GCAGGCTTCAGCTT-
CCACTC
TIMP-2-TTTGCAATGCAGATGTAGTG; TCGAGAAACTCC-
TGCTTGG
PAI-1-ACCTCTGAGAACTTCAGGATGC; TTCACCCAGTCATT-
GATGATG
uPA-GACTCCAAAGGCAGCAATG; CGATGGTGGTGAATT-
CTCC
uPAR-ATTGCCGTGTGGAAGAGTG; GGTGTCGTTGTTGTGG-
AAAC
G3PDH-GCCAAAAGGGTCATCATCTC; GTAGAGGCAGGG-
ATGATGTTC
Fluorescent collagen type I-degradation assay
Purified rat tail collagen was neutralized with NaOH and 10 mM
NaHPO4 to pH 7.5 at 0.25 mg/ml (total of 12.5 mg of collagen type
I) and to this solution 1 mg of fluorescein isothiocyanate was added.
This mixture was incubated at 4°C for 4-5 hours and was then
dialyzed exhaustively using 0.1% acetic acid in H2O. This sample was
lyophilized, resuspended in 0.1% acetic acid at 5 mg/ml and was
stored at 4°C. This fluorescent collagen preparation contained native
type I collagen as indicated by its resistance to cleavage by trypsin as
were our unlabelled collagen type I preparations. This fluorescent
collagen was diluted 1:20 into 3.75 mg/ml collagen gels containing
ECs. The cultures were established as described above except that
Medium 199 was utilized that did not contain phenol red. Prior to the
addition of the final medium containing growth factors, Medium 199
without phenol red but containing reduced serum supplement (100 m l)
was added for 30 minutes at 37°C to deplete phenol red from the
collagen gel mixture. This medium was then removed and replaced
with Medium 199 without phenol red with complete additives as
mentioned above. Conditioned medium was collected at various times
and saved for measurements of fluoresence. Medium (100 m l) was
placed into 96-well black Cliniplates (Labsystems, Helsinki, Finland)
and fluoresence was determined using a FLUOstar 403 microplate
fluorescence reader (BMG Lab Technologies, Durham, NC).
Construction of a recombinant adenovirus expressing the
TIMP-1 cDNA
The full length human TIMP-1 cDNA was amplified by RT-PCR using
KlenTaq polymerase (Clontech, Palo Alto, CA) from 8 hour EC
cDNA (Salazar et al., 1999) using the primers listed above with added
XhoI and EcoRV restriction enzyme sites in the upstream and
downstream primers, respectively. The ~700 bp insert was
unidirectionally cloned into pAdTrack-CMV (He et al., 1998) using
XhoI-EcoRV digested vector and insert. Clones were sequenced to
confirm the presence of the full length TIMP-1 cDNA and the absence
of mutations. Preparation of plasmid recombinants with pAdEasy-1
were performed and virus was produced in human 293 cells as
described (He et al., 1998). The pAdEasy adenoviral system was
kindly provided by Drs Bert Vogelstein and Tong-Chuan He from
Johns Hopkins University School of Medicine (Baltimore, MD). 
RESULTS
Development of a novel in vitro model of capillary
tube regression in three-dimensional collagen
matrix following the addition of plasminogen
Using a previously described model of capillary
morphogenesis in three-dimensional collagen matrices under
serum-free defined medium conditions (Davis and Camarillo,
1996), we have examined the role of proteinases by adding
plasminogen (Plg), which when converted to plasmin, can
activate MMPs (He et al., 1989; Jeffrey, 1998). Initial
experiments revealed that Plg addition did not effect the timing
or extent of capillary tube formation. However, by 48 hours
following Plg addition, the three-dimensional collagen gels
markedly contracted (Fig. 1). This response was a highly
reproducible event and occurred with collagen gels that
consisted of 5 (data not shown) or 3.75 mg/ml (Fig. 1) of rat
type I collagen. Because the latter dose of collagen was easier
to manipulate in our assays (Salazar et al., 1999), we chose this
concentration of collagen for the remaining experiments. The
starting diameter of the collagen gels was 4.5 mm, while
following contraction the gels were reduced to a diameter of ~
0.5 mm. In Fig. 1, it can be seen that the addition of Plg did
not affect EC morphogenesis prior to capillary tube regression
(Fig. 1A vs B). However, with increasing time, capillary tubes
in these cultures can be seen to undergo regression with
retraction of EC tubes and processes resulting in aggregates of
ECs and rounding of capillary tubes (Fig. 1C-F). Many
individual ECs are rounded up and are no longer present within
tube structures (Fig. 1E,F). The regression of capillary tubes
and the rounding up of individual and groups of ECs occurs
concurrently and progressively with the gel contraction
process. The regression of tubes is clearly evident at the point
where collagen gel contraction begins (Fig. 1C,D). After gel
contraction, it is apparent that individual ECs are rounded up
with no further evidence of morphogenesis (Fig. 1E,F). 
The EC tube regression events appear to occur in part
through an EC-mediated contractile mechanism. As shown in
Fig. 2, a time course of EC-mediated contraction is observed
on the same culture beginning at 37 hours of culture following
Plg addition (Fig. 2A), and proceeding over a 9 hour period to
fully contract (Fig. 2B-H). It should be noted that the entire
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EC-collagen gel culture contracted into the highly compact
state seen in Fig. 2H. Further experiments revealed that the EC
contraction event required an active actin cytoskeleton.
Cultures at the stage similar to that shown in Fig. 2A were
treated with 40 m M cytochalasin B. The addition of
cytochalasin B completely prevented the EC collagen gel
contraction process (data not shown).
Evidence that endothelial cell apoptosis occurs
during capillary tube regression in three-
dimensional collagen matrices
Further support for the concept that this system is a model for
capillary regression is that ECs appear to be undergoing
apoptosis during this event. Preliminary experiments indicated
that ECs were labelled by TUNEL
assays in the Plg but not the control
cultures (not shown). Using a
flow cytometry apoptosis assay
utilizing propidium iodide labelling
(Maxwell and Davis, 2000a;
Maxwell and Davis, 2000b) we have
examined EC DNA content after 60
hour of culture with or without Plg
addition. We observed an apoptotic
rate of 28% in the Plg-containing
cultures while only a 3% apoptotic
rate was observed in the cultures
without Plg. The apoptotic rate of
28% in the Plg-cultures is consistent
with strong apoptotic responses
that we have observed in previous
studies of p53-mediated tumor cell
apoptosis (Maxwell and Davis,
2000a; Maxwell and Davis, 2000b).
To more directly assess a role for
apoptosis, evidence for caspase-
dependent cleavage of proteins was
found to occur during the regression
process (Fig. 3). A well known target
of caspase-3 is gelsolin (Kothakota
et al., 1997; Kamada et al., 1998), an
actin cytoskeletal regulatory protein,
which we have previously shown is
markedly upregulated in expression
during capillary morphogenesis in
three-dimensional collagen matrices
(Salazar et al., 1999). Here, we show
that 8-16 hrs after the initiation of
collagen gel contraction, which
occurred in this time course between
40-48 hours, that a specific cleavage
of gelsolin occurred which was
blocked by the caspase inhibitor, Z-
VAD (Fig. 3). As shown in Fig. 3,
gelsolin expression is induced
during morphogenesis (with or
without added Plg) but was
selectively cleaved revealing a
fragment of 45-50 kDa only during
capillary regression. This result is
consistent with previous reports of
caspase-3 dependent cleavage of gelsolin (Kothakota et al.,
1997). Furthermore, we have observed a similar decrease in
intact 90 kDa gelsolin following the addition of anti- a 2b 1
integrin blocking antibodies (added at 40 hours of culture) but
not following the addition of control anti- a 5 blocking
antibodies (Fig. 3, lower panels). Interestingly, the anti- a 2
integrin antibodies induced marked regression of capillary
tubes and rounding of individual ECs without inducing
collagen gel contraction (Fig. 3). We have previously shown
that a 2b 1 regulates the formation of tube structures in collagen
type I matrices (Davis and Camarillo, 1996; Davis et al., 2000).
These data indicate that Plg-dependent capillary tube
regression induces an apoptotic response which is similar to
that observed following the blockade of integrin-dependent
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Fig. 1. Proteinase-dependent regression of capillary tubes in three-dimensional collagen matrices.
Human ECs were suspended into three-dimensional collagen matrices as described (Davis and
Camarillo, 1996) in the presence (A,C,D,E,F) or absence (B) of Plg and at various times of culture
were fixed and stained. Cultures were fixed at 30 hours (A,B) before the beginning of regression or
after various times of regression, 40 hours (C,D) or 46 hours (E,F). Arrowheads indicate clumps of
regressing EC tubes which consist of ECs that are rounded up and aggregated together. Arrows
indicate regressing capillary tubes (rounding up) (C,D) and small clusters of individual rounded up
ECs (F). Bars: 100 m m (A,B); 50 m m (C,D,F); 250 m m (E). 
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survival signals (Meredith et al., 1993; Boudreau et al., 1996)
and which also occurs following the blockade of the a 2b 1
integrin (Fig. 3).
We have also observed procaspase-3 cleavage (a reflection
of caspase-3 activation) in the Plg-containing cultures
consistent with an apoptotic response (Bossy-Wetzel and
Green, 1999) while this was not observed in control cultures
where a modest induction of caspase-3 protein was seen (Fig.
4A). The antibody used in this experiment does not detect
cleaved/activated caspase-3. This time course of cleavage is
earlier than that observed for gelsolin, a presumed caspase-3
target in this system (see Fig. 3), as decreased levels of
procaspase-3 were detectable as early as 48 hours, which
represents a time point several hours following full contraction
of the collagen gels. In contrast, actin protein was essentially
stable throughout in either set of cultures with or without Plg
except at the 72 hour time point where a reduction was
observed in the Plg containing culture. We have also observed
a marked change in the electrophoretic mobility of another
protein which is known to be proteolytically cleaved during
apoptotic responses, p130cas (Kook et al., 2000). The p130cas
protein, an adapter molecule and tyrosine kinase substrate in
the focal adhesion complex, is required for integrin-dependent
cell survival (Almeida et al., 2000). In Fig. 4, p130cas shows
a reproducible change in its electrophoretic mobility by
increasing its molecular mass in a time frame exactly
corresponding to the timing of collagen gel contraction. This
change is not observed in the cultures without Plg. In the time
course shown in Fig. 4A, collagen gel contraction occurred
between the 40 and 48 hour time points while in Fig. 4B, the
contraction response occurred between the 44 and 48 hour time
points in a separate time course. A clearly decreased mobility
of p130cas on SDS-PAGE gels was observed in between these
time points which indicates that this modification is a
biochemical marker of the contraction and regression response.
Interestingly, after this change occurs, the p130cas protein
disappears within approximately 8 hours, a likely indication of
proteolytic degradation. Interestingly, increased tyrosine
phosphorylation of p130cas is observed directly corresponding
to the timing of its decreased mobility in SDS-PAGE (Fig. 4B).
Interestingly, the disappearance of p130cas is observed using
both the p130cas and phosphotyrosine antibodies (Fig. 4A,B).
In a number of different cell types, this property of slower
electrophoretic mobility has been observed when the tyrosine
phosphorylated state of p130cas is increased (Sakai et al.,
1994). 
Matrix metalloproteinases and plasminogen
activators are induced during endothelial cell
morphogenesis in collagen matrices
To address whether MMPs or plasminogen activators (PAs) are
induced during capillary morphogenesis to regulate the
capillary regression process, we performed a series of time
course experiments. We have previously shown that the RT-
PCR technique allows for a convenient, semiquantitative
method to examine the differential expression of mRNAs
during capillary morphogenesis (Salazar et al., 1999). As
shown in Fig. 5A, an RT-PCR experiment shows the expression
of a series of proteinases as well as proteinase inhibitors in
control cultures over time. Marked induction of mRNAs for
MMP-1, MMP-3, MMP-9, MT1-MMP, and uPA were
observed. The expression patterns of many of these genes have
been confirmed at the protein level using gelatin zymogram and
western blot analyses (see below). In contrast, MMP-2 mRNA
was downregulated at 8 hours of culture only to be upregulated
to near baseline by 48 hours of culture. Interestingly, TIMP-1
was upregulated at 8 hours and then downregulated to baseline
by 48 hours while TIMP-2 was gradually downregulated over
the 48 hour time period. Both PAI-1 and uPA receptor were
upregulated at 8 hrs and then markedly downregulated by 48
hours. The expression of the control mRNA, G3PDH, was
stable over the time course.
In Fig. 5B and C, gelatin zymograms show marked induction
of a number of proteolytic enzymes during these events.
Conditioned medium from control Plg-free cultures over time
was collected and run on SDS-PAGE gels containing gelatin
and Plg (to examine PAs) (Fig. 5B). Marked induction of uPA
was observed while tPA also appeared to be induced but to a
lesser extent than uPA (Fig. 5B). Other experiments examined
MMP expression in the absence or presence of plasminogen
Fig. 2. Time course of plasminogen-induced endothelial cell
contraction of three-dimensional collagen matrices. Human ECs
were suspended into three-dimensional collagen matrices as
described (Davis and Camarillo, 1996) in the presence of 2 m g/ml of
Plg and at 37 hours of culture, a series of transmitted light
photographs were taken of the same culture. (A) 37 hours; (B) 38
hours; (C) 39 hours; (D) 40 hours; (E) 41 hours; (F) 42 hours; (G) 45
hours; (H) 46 hours. Bar, 500 m m.
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added to the culture medium (Fig. 5C) to investigate
differences between control cultures versus cultures
undergoing collagen gel contraction and capillary regression.
In the control cultures, MMP-9 was shown to be induced as
well as bands corresponding to MMP-2. An activated form of
MMP-2 was observed to be markedly induced while pro-
MMP-2 was present in conditioned medium as early as 4 hours
and likely reflects constitutive synthesis of MMP-2 (Fig. 5C,
upper panel). This conclusion was also supported by the
mRNA expression pattern observed in Fig. 5A. In contrast, in
the cultures with added Plg, MMP-9 appears to be processed
into a lower molecular mass form indicative of its activation
(Davis and Martin, 1990; Vu and Werb, 1998) while MMP-2
activation appears similar to that observed
from cultures without added Plg. In addition,
we have observed bands (~30 kDa) on these
gels (indicated by the arrows) which are
induced following Plg addition and during
capillary regression events. The identity of
these proteinases remains unclear as the
activity of these bands was not inhibited by
EDTA, serine protease inhibitors or various
cathepsin inhibitors (not shown). 
We have also performed western blot
analysis to confirm the protein induction
patterns for MMP-1 and MMP-9 (Fig. 6A).
Dramatic induction of MMP-1 was observed,
and interestingly, the addition of Plg resulted
in the appearance of several lower molecular
mass bands indicative of MMP-1 activation
(Fig. 6A). The same result was observed with
MMP-9 which is consistent with the gelatin
zymogram results shown above (Fig. 5C).
The antiserum utilized for the MMP-9
western blots also recognizes TIMP-1 since
it was derived from rabbit immunizations
with the MMP-9/TIMP-1 complex (Davis
and Martin, 1990). Some induction of TIMP-
1 protein was observed (Fig. 6A, lower panel)
which is consistent with the RT-PCR data
(Fig. 5A). Thus far, we have been unable to
detect the production of MMP-3 on western
blots despite evidence for induction of its
mRNA using RT-PCR. Under the same
conditions, we detected abundant MMP-3
release into conditioned medium by human
fibroblasts (not shown). 
Involvement of matrix
metalloproteinases and plasminogen
activators in plasminogen-induced
contraction of collagen matrices and
capillary tube regression
To determine a role for MMPs and/or PAs in
Plg-induced capillary regression, experiments
were performed using known inhibitors with
specificity for different proteinases. The
addition of aprotinin (a plasmin inhibitor),
PAI-1 (a PA inhibitor), TIMP-1 and TIMP-2
(MMP inhibitors) and a 2-macroglobulin (a
broad spectrum protease inhibitor) completely
inhibited Plg-induced collagen matrix contraction (Table 1). In
contrast, the thrombin inhibitor, hirudin, had no effect. The
results with TIMP-1 were also reproduced by overexpressing
TIMP-1 in ECs using a recombinant adenovirus which prevented
Plg-dependent collagen gel contraction and capillary regression
while a control adenovirus had no effect (data not shown). Two
low molecular mass inhibitors of MMPs, GM6001 (Galardy et
al., 1994) and MMP inhibitor I (Odake et al., 1994), were also
shown to inhibit the contraction process. Dose-response curves
for each inhibitor were performed showing that complete
inhibition was observed at doses above 50 nM for GM6001 (Fig.
6B) or above 16-32 m M for MMP inhibitor I (Fig. 6C). Also,
western blots were performed to examine whether MMP-1
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Fig. 3. Caspase-dependent cleavage of gelsolin occurs during proteinase-dependent
capillary regression in three-dimensional collagen matrices. Human ECs were suspended
into three-dimensional collagen matrices as described (Davis and Camarillo, 1996) in the
presence or absence of 2 m g/ml of Plg and in the presence or absence of Z-VAD (100
m M). Extracts were made of EC cultures at the indicated times (three upper panels) and
western blots were performed using anti-gelsolin antibodies. Arrows indicate the position
of a gelsolin fragment at 45-50 kDa. The lower panel cultures were treated with either no
antibody or 20 m g/ml of anti-integrin antibodies directed to the a 2 or a 5 subunits at 40
hours of culture. Extracts were made of EC cultures at the indicated times (middle panel)
and western blots were performed using anti-gelsolin antibodies. Photographs of fixed
and toluidine blue stained cultures treated with anti-integrin antibodies were taken 16
hours after addition (at 56 hours) (lower panels). Bar, 100 m m. 
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Fig. 4. Caspase-3 cleavage
and alterations in p130cas
occur during plasminogen-
induced collagen gel
contraction and capillary
regression in three-
dimensional collagen
matrices. Western blots were
performed using EC collagen
gel culture (with and without
added Plg) extracts prepared
at the indicated times of
cultures. (A) Blots used
antibodies directed to
caspase-3, actin, and p130cas.
Arrow indicates the position
of a p130cas band that
migrates with a slower
electrophoretic mobility.
(B) Blots used antibodies directed to p130cas and phosphotyrosine. Arrow indicates the position of a p130cas and phosphotyrosine-containing
band that migrates with a slower electrophoretic mobility. 
Fig. 5. Differential expression of matrix
metalloproteinases, plasminogen activators, and
proteinase inhibitors during capillary
morphogenesis in three-dimensional collagen
matrices. (A) Analysis of mRNA expression for
proteinases and proteinase inhibitors during
capillary morphogenesis in three-dimensional
collagen matrices. Human ECs were suspended
into three-dimensional collagen matrices, total
RNA was obtained at 0, 8, 24 and 48 hours and
semiquantitative RT-PCR was performed as
described (Salazar et al., 1999). Samples were
run on agarose gels and the PCR products were
analyzed. The G3PDH product was used as a
standard which showed equivalent amounts of
starting cDNA for each sample as indicated by
equivalent amounts of product in the four
samples. (B) Gelatin zymography showing
induction of plasminogen activators during
capillary morphogenesis. Conditioned medium at
different times of EC morphogenesis was loaded
on SDS-PAGE gels containing gelatin and
plasminogen. The position of the bands also
corresponds to standards loaded for either t-PA or
u-PA. (C) Gelatin zymography showing
induction and activation of matrix
metalloproteinases in endothelial cell-collagen
cultures in the absence or presence of
plasminogen. Human ECs were suspended into
three-dimensional collagen matrices as described
(Davis and Camarillo, 1996) in the presence or
absence of 2 m g/ml of Plg. Conditioned medium
was collected at various times of culture and was
loaded on SDS-PAGE gels containing gelatin
only. Arrowheads show MMP-9 and MMP-2 latent versus activated bands (MMP-9a, MMP-2a) while the arrows indicate bands observed
which have not been identified. 
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activation was blocked by the addition of these inhibitors.
Interestingly, there was a direct correlation between the presence
of activated MMP-1 and whether capillary regression occurred.
In these dose-response curves, intermediate levels of activated
MMP-1 correlated with partial gel contraction and regression
(Fig. 6B,C). When MMP-1 activation was inhibited, EC
morphogenesis occurred in a normal manner with no regression
(Fig. 6C). There was also a direct correlation with inhibition of
MMP-9 activation and lack of regression (data not shown).
An additional experiment addressed potential mechanisms
regulating Plg activation during this process. A number of
studies have shown that cell surface binding of Plg and the
process of Plg activation is enhanced by proteins or peptides
containing C-terminal lysine residues (Redlitz et al., 1995;
Nesheim, 1998; Hajjar and Krishnan, 1999). To address
whether such residues may play a role in the capillary
regression process here, varying doses of the enzyme
carboxypeptidase B were added to the culture medium. This
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Fig. 6. Induction and activation of matrix
metalloproteinases during capillary
morphogenesis and following plasminogen
addition. (A) Western blot analysis showing
marked induction and activation of MMP-1 and
MMP-9 during plasminogen-induced endothelial
cell contraction of collagen matrices. Conditioned
medium was collected at various times of culture
and samples were loaded on 8.5% SDS-PAGE and
after blotting to PVDF membranes, blots were
probed with antibodies directed to MMP-1 (41-
1E5) (upper panels) or the MMP-9/TIMP-1
complex (lower panels). The blots on the left were
derived from conditioned medium obtained from
cultures without Plg while the blots on the right
were derived from medium obtained from cultures
with added Plg. Arrowheads indicate the position
of latent versus activated MMP protein bands.
(B) Effect of MMP inhibitor GM6001 on
plasminogen-induced collagen gel contraction.
Varying doses of GM6001 were added to cultures
in the presence of plasminogen and after 48 hours,
cultures were fixed and conditioned medium was
collected. Cultures were examined for collagen gel
contraction (gel diameter averages of three
independent gels are indicated in parenthesis
under gel lanes) and medium was examined for
MMP-1 activation by western blot analysis. Doses
of GM6001 are indicated over the lane showing
MMP-1 bands. Arrow indicates the position of an
activated form of MMP-1. (C) Effect of MMP
inhibitor I on plasminogen-induced endothelial
cell contraction of collagen matrices. Human ECs
were suspended into three-dimensional collagen
matrices in the presence of 2 m g/ml of Plg and in
the presence or absence of various doses of MMP
inhibitor I. Cultures were fixed at 48 hours with
glutaraldehyde and the area of the contracted or
non-contracted gels was determined by measuring
the average diameter (average of two
perpendicular measurements) of triplicate gels.
The data is expressed as the mean area ± standard
deviation. Representative fields of the indicated
doses (arrows) of MMP inhibitor I were
photographed after fixation and toluidine blue
staining. SDS-PAGE gels were run using
conditioned medium samples derived from this
dose response. The samples were run, blotted and
probed with anti-MMP-1 antibodies to detect the
bands. Arrows indicate the position of an activated
form of MMP-1.
925Proteinase-dependent capillary tube regression 
enzyme degrades C-terminal lysine and arginine residues and
has been reported to inhibit fibrinolysis through decreased
plasmin generation (Redlitz et al., 1995; Nesheim, 1998).
Carboxypeptidase B induced a dose-dependent inhibitory
effect on Plg-dependent collagen gel contraction and capillary
tube regression (Fig. 7). Interestingly, the addition of the
enzyme also blocked MMP-1 activation (probably acting
through decreased plasmin generation) showing again the
correlation of capillary tube regression with the presence of
activated MMP-1. 
Endogenous production of PAI-1 by endothelial cells
negatively regulates plasminogen-induced capillary
tube regression and collagen gel contraction 
As shown in Fig. 5A, a series of EC proteinase inhibitors were
found to be differentially regulated during EC morphogenesis.
To address whether EC-derived PAI-1 played a role in
regulating the Plg-induced contraction event, blocking
antibodies were added. As shown in Table 2, Plg-induced
contraction occurred more rapidly (within 24-29 hours) in the
presence of both Plg and blocking antibodies to PAI-1 than in
controls with Plg alone. In contrast, no effect was observed
with control blocking antibodies directed to PAI-2. In addition,
the ability of anti-PAI-1 antibodies to accelerate regression was
only observed in the presence of Plg and not in its absence
(Table 2). This response was even more rapid when anti-PAI-
1 and Plg were added after 24 hours of culture, as contraction
was observed at 12-16 hours following addition (data not
shown). The accelerated contraction response with anti-PAI-1
antibodies was blocked by the addition of the proteinase
inhibitors, PAI-1, aprotinin, TIMP-1, TIMP-2 and MMP
inhibitor I indicating that the effect was both plasmin and
MMP-dependent (Table 2).
Blocking antibodies to MMP-1, MMP-9 and MMP-2
interfere with plasminogen-induced capillary
regression and contraction of collagen matrices
As shown above, marked increases in the production of MMP-
1 and MMP-9 occurred during EC morphogenesis as well as
marked increases in the presence of activated forms of MMP-
2 (with or without Plg), MMP-1 (only with Plg) and MMP-9
(only with Plg). To address whether these activated MMPs
directly participated in the process of Plg-induced contraction
of collagen matrices, blocking monoclonal antibodies were
added during the process. As shown in Fig. 8, blocking
antibodies directed to MMP-1, MMP-2 and MMP-9, all
independently blocked collagen gel contraction. In contrast, a
non-blocking antibody to MMP-1 as well as a control anti-
integrin antibody to the a 5 subunit, had no blocking effect. The
addition of the blocking MMP-1 antibody interfered with the
Table 1. Regression of capillary morphogenesis (collagen
matrix contraction) in three-dimensional collagen
matrices in response to plasminogen and various
proteinase inhibitors
Collagen matrix Gel area 
Proteinase inhibitor contraction (mm2) 
None + 0.32
Hirudin (1000 U/ml) + 0.41
Aprotinin (910 KIU/ml) - 16.0
Aprotinin (2900 KIU/ml) - 16.0
PAI-1 (2.5 m g/ml) - 16.0
PAI-1 (10 m g/ml) - 16.0
TIMP-1 (1 m g/ml) - 16.0
TIMP-1 (2.5 m g/ml) - 16.0
TIMP-2 (1 m g/ml) - 16.0
TIMP-2 (2.5 m g/ml) - 16.0
a 2-macroglobulin - 16.0
Addition of plasminogen occurred at a culture time of 24 hours at 2 m g/ml
and were measured 48 hours after plasminogen addition. Collagen gel areas
were determined by calculating the average values from 4 independent
cultures.
(- ) No regression (gel area = 16 mm2).
(+) Regression (gel area ł0.5 mm2).
Table 2. Acceleration of endothelial cell-mediated collagen
gel contraction and capillary regression by anti-PAI-1
blocking antibodies 
Collagen matrix Gel area 
Culture conditions contraction (mm2)
Plg alone - 16.0
Plg + a PAI-2 - 16.0
No Plg + a PAI-1 - 16.0
Plg + a PAI-1 + 0.45
Plg + a PAI-1 + BSA + 0.43
Plg + a PAI-1 + PAI-1 - 16.0
Plg + a PAI-1 + aprotinin - 16.0
Plg + a PAI-1 + TIMP-1 - 16.0
Plg + a PAI-1 + TIMP-2 - 16.0
Plg + a PAI-1 + MMP inhibitor I - 16.0
Addition of plasminogen and other reagents occurred at 0 hours of culture
and cultures were fixed at 29 hours. The anti-PAI-1 and anti-PAI-2 polyclonal
antibodies were added at 100 m g/ml. Gel areas were determined by measuring
the areas of three independent cultures and calculating the average.  In
addition, proteinase inhibitors were added at the following concentrations.
Aprotinin, 2900 KIU/ml; PAI-1, 10 m g/ml; TIMP, 1- 2.5 m g/ml; TIMP-2,
2.5 m g/ml; MMP inhibitor I, 175 m M.  
Fig. 7. Effect of carboxypeptidase B on plasminogen-induced
endothelial cell contraction of collagen matrices. Cultures were
established in the presence of 2 m g/ml of Plg and in the presence of
varying doses of carboxypeptidase B. Cultures were fixed after 48
hours and were quantitated for collagen gel diameter. Triplicate
cultures were examined and the values shown represent the mean ±
standard deviation of these values. Conditioned medium samples
derived from the dose-response curve were run on SDS-PAGE gels
and western blots performed with anti-MMP-1 antibodies. Lane 1,
0.0316 m g/ml medium; lane 2, 0.1 m g/ml medium; lane 3, 0.316
m g/ml medium; lane 4, 1 m g/ml; lane 5-3.16 m g/ml. Arrow indicates
an activated form of MMP-1.
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generation of activated MMP-1, while control antibodies did
not, accounting for its effects on collagen gel contraction
(Fig. 8). These data show that at least three MMPs directly
participate in this contraction and regression process. 
Evidence that collagen degradation is the
mechanism for matrix metalloproteinase-induced
collagen gel contraction and capillary tube
regression
To address whether the induction and activation of MMPs
results in detectable collagen type I degradation, experiments
were performed using a fluorescent collagen type I degradation
assay. For these experiments, type I collagen was labelled with
fluorescein and incorporated into the three-dimensional
collagen assay. Cultures were established and conditioned
medium was collected at various times and assayed for
fluorescence using a fluoresence microplate reader. In Fig. 9A,
it is shown that a marked fluorescence release was detectable
in the culture medium only following Plg addition and
subsequent contraction. This release of fluorescent collagen
was observed between 24 and 48 hrs, corresponding to the
timing of the contraction event. In addition, this coincides with
the temporal time frame when activated forms of MMP-1 and
MMP-9 were detected (see Fig. 6A). We observed that release
of fluorescent collagen degradation products only occurred
following the addition of Plg. This fluorescent release
accounted for 32±8% (n=4) of the total fluorescent material
present in the collagen gels. The addition of the proteinase
inhibitors, aprotinin, PAI-1, TIMP-1 and TIMP-2 completely
blocked fluorescent collagen release (Fig. 9B). These data
show that fluorescent release of collagen degradation products
directly correlates with Plg addition and capillary regression,
and is blocked by plasmin, PA and MMP inhibitors. These data
suggest that collagen degradation by EC proteinases regulates
the contraction and regression process. 
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Fig. 8. Effect of blocking monoclonal antibodies directed to
matrix metalloproteinases on plasminogen-induced endothelial
cell contraction of collagen matrices. Human ECs were
suspended into three-dimensional collagen matrices as described
(Davis and Camarillo, 1996) in the presence of 2 m g/ml of Plg
and in the presence or absence of 20 m g/ml of monoclonal
antibodies directed to various MMPs and the a 5 integrin. In one
case, two different antibodies were mixed. Cultures were fixed
at 48 hours with glutaraldehyde and the area of the contracted or
non-contracted gels was determined by measuring the average
diameter (average of two perpendicular measurements) of
triplicate gels from two independent experiments. The data is
expressed as the mean area ± standard deviation. The figure
inset shows an anti-MMP-1 western blot of conditioned medium
of several of these cultures. The SDS-PAGE gel was run under
non-reducing conditions. The arrow indicates an activated form
of MMP-1. Lane 1, non-blocking anti-MMP-1 antibody
medium; lane 2, control a 5 integrin control antibody medium;
lane 3, control medium – no antibody added; lane 4, blocking
anti-MMP-1 antibody medium. 
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A
BFig. 9. Fluorescent collagen degradation and release duringplasminogen-induced endothelial cell contraction of collagen
matrices. Collagen type I was labelled with fluorescein and was
incorporated into the endothelial cell-collagen gel mixture. The
cultures were established in the presence or absence of added Plg
using Medium 199 culture medium without phenol red. At various
times of culture, conditioned medium was collected and assayed for
fluorescence using a microplate fluorescent reader. (A) Fluorescence
readings (average ± standard deviation) from six independent
cultures are shown for 0, 24 and 48 hours cultures in the presence or
absence of Plg. (B) Additional experiments collected conditioned
medium from cultures containing proteinase inhibitors (48 hours).
Fluorescence readings (average ± standard deviation) from six
independent cultures cultured in the presence of Plg in the presence
or absence of the indicated proteinase inhibitors. 
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DISCUSSION
Plasminogen induces matrix-metalloproteinase-
dependent regression of capillary tube networks in
three-dimensional collagen matrices
Previous work has shown that Plg is an important molecule
regulating wound healing responses (Pepper et al., 1996; Clark,
1996; Mignatti et al., 1996; Carmeliet and Collen, 1998; Lund
et al., 1999). It is also the precursor of plasmin, an important
fibrinolysin, as well as a known activator of MMPs such as
MMP-1, MMP-3, and MMP-9 (He et al., 1989; Okumura et
al., 1997; Jeffrey, 1998; Murphy and Gavrilovic, 1999; Ramos-
DeSimone et al., 1999). In previous studies, Plg has been
shown to play a role in inducing regression of blood vessels.
A fragment of Plg, termed angiostatin, has been shown to
inhibit angiogenesis and affect tumor growth (O’Reilly et al.,
1994). Angiostatin has been shown to influence a number of
EC properties related to angiogenic responses such as
proliferation, apoptosis and migration (O’Reilly et al., 1994;
Lucas et al., 1998; Redlitz et al., 1999). The data presented here
support the hypothesis that Plg caused capillary regression by
its conversion to plasmin, which caused MMP activation and
subsequent collagen matrix degradation. Whether angiostatin
can influence plasmin generation or MMP activation is unclear
at present, although one study suggests that angiostatin may
inhibit plasmin generation at the cell surface by competing for
Plg cell surface-binding sites (Stack et al., 1999). The binding
of Plg to ECs and other cell types has been shown to involve
C-terminal lysine residues in cell surface Plg-binding proteins
such as annexin II (Hajjar and Krishnan, 1999). It seems likely
that our results represent a distinct mechanism for Plg-induced
capillary regression compared to that reported for angiostatin
since it does not have intrinsic proteolytic activity (O’Reilly et
al., 1994). 
Matrix metalloproteinases are induced and activated
during endothelial cell morphogenesis and directly
participate in plasminogen-induced capillary
regression in three-dimensional collagen matrices
The work presented here shows that a number of proteolytic
enzymes are differentially expressed during EC morphogenesis
in collagen matrices which is consistent with previous studies
(Mignatti et al., 1989; Fisher et al., 1994; Cornelius et al., 1995;
Iruela-Arispe et al., 1995; Pepper et al., 1996; Haas et al., 1998;
Hiraoka et al., 1998; Werb et al., 1999). We provide evidence
for induced activation of MMP-1, MMP-2, and MMP-9.
Interestingly, activated states for MMP-1 and MMP-9 were
only observed following Plg addition, while MMP-2 was
similarly activated with or without Plg addition, likely due to
activation by MT-MMPs (Will et al., 1996; Foda et al., 1996;
Deryugina et al., 1998; Knauper and Murphy, 1998). Despite
the presence of activated MMP-2 in cultures without Plg,
activated MMP-2 alone is not sufficient to induce EC-mediated
collagen gel contraction. Plasmin-mediated activation of
MMP-1 and MMP-9 is required in conjunction with activated
MMP-2 for this event. 
Our data with blocking monoclonal antibodies to MMPs
suggests that MMP-1, MMP-2 and MMP-9 all participate and
are independently required for Plg-induced collagen gel
contraction. The substrate specificities of these three MMPs are
different (Vu et al., 1998; Jeffrey, 1998; Yu et al., 1998). In
particular, MMP-1 is efficient in degrading native collagen type
I, while MMP-2 and MMP-9 are very efficient in degrading
denatured collagen type I. Perhaps the degradation of both
native and denatured collagen type I are necessary for collagen
gel contraction and thus, capillary regression.
Endothelial cell apoptosis occurs during matrix
metalloproteinase-dependent capillary regression in
three-dimensional collagen matrices
The data presented here also supports the concept that matrix
metalloproteinase-dependent capillary regression in three-
dimensional collagen matrices leads to EC apoptosis. This
information further validates our system as a model for
capillary tube regression. Western blot experiments provided
evidence for caspase-dependent cleavage of the known
caspase-3 target, gelsolin, as well as caspase-3 itself, during
plasminogen-dependent capillary regression. In addition, anti-
a 2 integrin antibodies which cause marked regression of pre-
existing capillary tubes (Fig. 3), also showed marked decreases
in intact gelsolin in a time course similar to that of matrix
metalloproteinase-induced regression (Fig. 3). These data
support the concept that EC apoptosis is occurring secondary
to decreased or altered cell-matrix contacts leading to cell
rounding, a feature common to both the effects of Plg or anti-
integrin antibody addition (see Figs 1 and 3). Loss of cell-
matrix contacts is well known to induce apoptosis in ECs
and other cells (Meredith et al., 1993; Boudreau et al., 1996;
Werb et al., 1996). In support of such conclusions was the
observation that alterations in p130cas occurred during the Plg-
induced regression response. The p130cas protein is an
important adapter molecule and tyrosine kinase substrate in the
focal adhesion complex necessary to support cell survival
in response to cell-ECM signals (Almeida et al., 2000).
Decreased electrophoretic mobility of p130cas was seen along
with increased tyrosine phosphorylation of the protein which
directly correlated temporally with the contraction and
regression events. This data suggests that alterations in signals
derived from the focal adhesion complex may be an important
component of the apoptotic response in this system. The
proteolytic removal of the p130cas protein within an 8 hour
period following this mobility shift supports this idea. 
A novel in vitro model for endothelial cell-mediated
collagen gel contraction and regression of capillary
tubes in three-dimensional collagen matrices
The work described here presents a novel in vitro model for
capillary tube regression that involves MMP activation and
depends on MMP-dependent proteolysis of collagen matrices.
Many in vitro studies have focused on the question of
how capillary tubes assemble in three-dimensional ECM
environments (Montesano and Orci, 1985; Vernon and Sage,
1995; Pepper et al., 1996; Davis and Camarillo, 1996; Bayless
et al., 2000). In contrast, few studies have investigated
mechanisms of capillary tube regression in three-dimensional
ECM (Zhu et al., 2000). Much recent work has concentrated
on molecules or mechanisms to induce vascular regression in
vivo as a way to inhibit tumor survival, growth and progression
(Brooks et al., 1994; Senger et al., 1997; O’Reilly et al., 1994;
O’Reilly et al., 1997; Browder et al., 2000). However, the
complexity of these in vivo systems make it difficult to identify
the molecular pathways which regulate these phenomena. 
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To address these issues, we developed a highly reproducible
microassay to study the molecular regulation of human
capillary tube regression. This regression mechanism directly
involves two apparently related phenomena which are EC-
mediated collagen degradation and EC-matrix contractile
behavior. Several previous studies have revealed that collagen
gel contraction by various cells can be inhibited by proteinase
inhibitors (Deryugina et al., 1998; Vernon and Sage, 1996;
Myers and Wolowacz, 1998; Scott et al., 1998). It should be
pointed out that the collagen gels utilized in our studies are
very dense (3.75 or 5 mg/ml collagen type I) compared to many
previous studies concerning cell-mediated collagen gel
contraction (usually 1-1.5 mg/ml) (Schiro et al., 1991). The
ability of ECs to contract gels of this density is quite
remarkable suggesting either a marked ability to generate cell-
matrix contractile forces and/ or to degrade collagen matrices.
Previous studies have shown that ECs can mechanically distort
ECM which has effects on the ability of ECs to undergo
morphogenesis and organize into planar cord structures
(Vernon et al., 1992; Vernon and Sage, 1995; Davis and
Camarillo, 1995). It is also important to consider that ECs
undergoing morphogenesis have formed interconnected
multicellular structures (i.e. networked tubes) which may allow
increased generation of mechanical forces compared to
individual cells (i.e. fibroblasts) interacting with ECM. An
interesting question is the extent to which ECs undergoing
angiogenesis in a wound site may participate in the known
phenomenon of wound contraction, since there is some overlap
in the time frames for capillary regression and wound
contraction during wound healing (Clark, 1996). 
In addition, blood vessel formation is followed in a
controlled temporal manner by blood vessel regression in the
normal wound healing process (Clark, 1996; Madri et al.,
1996). When this process is abnormal, such as in chronic
wounds, diabetic retinopathy or cancer, this vasculature
remains and does not regress suggesting that normal vascular
regression responses may be circumvented. One possibility is
that regression inhibitors are present in these situations which
prevent the normal regression process. The data presented
with EC-derived PAI-1 negatively regulating Plg-induced
contraction illustrates this point. Blocking antibodies to PAI-1
markedly accelerated the regression and contraction process
(see Table 2). Also in support of this idea, are recent in vivo
studies implicating a role for PAI-1 in the prevention of
vascular regression and in the facilitation of tumor growth and
angiogenesis (Bacharach et al., 1998; Bajou et al., 1998).
Furthermore, recent data indicate that PAI-1 is a hypoxia-
induced gene along with VEGF (Pinsky et al., 1998) indicating
that inhibition of the proteinase-induced regression mechanism
described here may be an important feature of angiogenic
responses. 
Two classes of proteinases controlling the collagen gel
contraction and regression response presented here are plasmin
(generated from Plg and PAs) and MMPs (MMP-1, MMP-2
and MMP-9). It is interesting that these two classes of enzymes
can either separately or in combination degrade both fibrin and
collagen matrices, which are the most biologically relevant
ECM environments where blood vessel formation and
regression take place (Vernon and Sage, 1995; Senger, 1996;
Pepper et al., 1996). Thus, our work strongly implicates
plasmin and MMP-mediated degradation of extracellular
matrix as a major mechanism controlling regression of
capillary tube networks. 
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